SMW Free Realtime Trade Alerts -- Our Last 2 Trade Alerts were VII and NFEC, easy 40-75% wins in minutes, Join Today for FREE!!
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Loading NKTR News...
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||2.31%||88.55||1.6%||$823.72m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.91%||394.90||3.1%||$311.76m|
|ALXN||Alexion Pharmaceuticals, Inc.||1.32%||127.46||2.6%||$257.08m|
|BMRN||BioMarin Pharmaceutical Inc.||-0.84%||92.79||3.9%||$192.43m|
|VRTX||Vertex Pharmaceuticals Incorporated||2.00%||95.77||1.7%||$133.83m|
|JUNO||Juno Therapeutics, Inc.||0.65%||29.32||7.9%||$104.16m|
|A||Agilent Technologies, Inc.||-0.92%||46.15||1.9%||$93.70m|
|ALNY||Alnylam Pharmaceuticals, Inc||1.08%||66.20||5.2%||$63.94m|
Nektar Therapeutics is a clinical-stage biopharmaceutical company, which engages in developing drug candidates that utilize its PEGylation and polymer conjugate technology platforms. Its products includes of drug candidates of therapeutic areas, including oncology, pain, anti-infectives, anti-viral and immunology. The company provides small molecule drugs, peptides and other potential biologic drug candidates. Its drug candidates are designed to improve the pharmacokinetics, pharmacodynamics, half-life, bioavailability, metabolism or distribution of drugs and improve the overall benefits and use of a drug for the patient. The company was founded in 1990 and is headquartered in San Francisco, CA.